Mineralys Therapeutics
A Director / Senior Director role at Mineralys Therapeutics focused on commercial operations to support the development and launch of lorundrostat in hypertension. The role involves guiding CRM implementation, managing commercial incentive compensation, field alignment, sample operations, and fleet logistics.
Headquarters
Radnor, Pennsylvania, United States
Company Size
11-50 employees
Founded
2020
Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on improving outcomes for people with hypertension, chronic kidney disease (CKD), and cardio-renal-metabolic diseases driven by dysregulated aldosterone. The company's lead investigational candidate, Lorundrostat, is designed to target the underlying role of aldosterone in these conditions. Mineralys is advancing its pipeline through clinical development with the goal of delivering better outcomes for patients inadequately served by current therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Mineralys Therapeutics.
106% above the average for this role
Decoding Mineralys Therapeutics Inc (MLYS): A Strategic SWOT Insight
3 days ago
Director, Commercial Operations-East
Jobgether
Senior Director, Field Operations
Vertex
Associate Director, Commercial Operations
Zydus Therapeutics
Director, US Commercial Enablement
Dyne Therapeutics
Executive Director, Field Force Effectiveness
ionis
Executive Director, Field Operations Strategy & Excellence
Travere Therapeutics